ZB
ALXN

Zions Bancorporation’s Alexion Pharmaceuticals ALXN Stock Holding History

Zions Bancorporation’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-149
Closed -$27K – 1081
2021
Q2 		$27K Buy
149
+3
+2% +$515 ﹤0.01% 533
2021
Q1 		$22K Sell
146
-3,972
-96% -$614K ﹤0.01% 560
2020
Q4 		$643K Sell
4,118
-9
-0.2% -$1.16K 0.08% 104
2020
Q3 		$472K Sell
4,127
-273
-6% -$29.5K 0.07% 117
2020
Q2 		$494K Buy
4,400
+1,060
+32% +$113K 0.07% 104
2020
Q1 		$300K Buy
3,340
+1,420
+74% +$139K 0.05% 128
2019
Q4 		$208K Sell
1,920
-164
-8% -$17.5K 0.03% 216
2019
Q3 		$204K Buy
+2,084
New +$235K 0.03% 244
2018
Q4 		– Sell
-379
Closed -$53K – 814
2018
Q3 		$53K Buy
+379
New +$47.5K 0.01% 324
2017
Q4 		– Sell
-655
Closed -$92K – 1030
2017
Q3 		$92K Buy
655
+636
+3,347% +$86.4K 0.01% 447
2017
Q2 		$2K Sell
19
-51
-73% -$5.94K ﹤0.01% 618
2017
Q1 		$7K Sell
70
-53
-43% -$6.83K ﹤0.01% 454
2016
Q4 		$15K Sell
123
-32
-21% -$3.92K ﹤0.01% 440
2016
Q3 		$19K Buy
155
+54
+53% +$6.95K ﹤0.01% 389
2016
Q2 		$13K Sell
101
-64
-39% -$9.08K ﹤0.01% 416
2016
Q1 		$24K Buy
165
+3
+2% +$440 ﹤0.01% 351
2015
Q4 		$23K Sell
162
-5
-3% -$873 ﹤0.01% 335
2015
Q3 		$29K Buy
+167
New +$30.5K 0.01% 290
2015
Q2 		– Sell
-145
Closed -$25K – 801
2015
Q1 		$25K Buy
+145
New +$26.2K ﹤0.01% 329

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Zions Bancorporation's ALXN Position: Q3 2021 in Review

Zions Bancorporation sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 149 shares — an estimated $27K sold.

Zions Bancorporation first reported a position in ALXN in Q1 2015 and held it in 19 quarters. The position peaked at $643K in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Zions Bancorporation reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Zions Bancorporation sold 149 Alexion Pharmaceuticals shares in Q3 2021, an estimated $27K.
  • Zions Bancorporation first reported a position in Alexion Pharmaceuticals in Q1 2015 and held it in 19 quarters.
  • Zions Bancorporation's Alexion Pharmaceuticals position peaked at $643K in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Zions Bancorporation's 13F filing for Q3 2021, filed 10 Nov 2021.